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Background: Drp1 is the primary protein responsible for mitochondrial fission. Perturbations of mitochondrial
morphology and increased fission are seen in neurodegeneration. While Drp1 degradation induced by Parkin
overexpression can be prevented by proteasome inhibition, there are numerous links between proteasomal and
autophagic processes in mitochondrial protein degradation. Here we investigated the role of autophagy in
Drp1 regulation.
Results: We demonstrate that autophagy plays a major role in the control of Drp1 levels. In HEK-293T cells,
inhibitors of autophagy increase total Drp1 and levels of Drp1 in the mitochondrial cellular fraction. Similarly by
silencing ATG7, which is required for initiation of autophagy, there is an increased level of Drp1. Because of the role
of increased Drp1 in neurodegeneration, we then examined the ability to modulate Drp1 levels in neurons by
inducing autophagy. We are able to decrease Drp1 levels in a time- and dose-dependent manner with the potent
neuronal autophagy inducer 10-NCP, as well as structurally related compounds. Further, 10-NCP was able increase
average mitochondrial size and length verifying a functional result of Drp1 depletion in these neurons.
Conclusions: These pharmacological and genetic approaches indicate that autophagy targets Drp1 for lysosomal
degradation. Additionally these data suggest a mechanism, through Drp1 downregulation, which may partly
explain the ability of autophagy to have a neuroprotective effect.
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Mitochondria are dynamic organelles undergoing con-
stant changes in size and shape. This perpetual cycle of
fusion and fission is a delicate balancing act and is
critical for proper cellular function [1]. Mitochondrial
morphology is regulated by the opposing actions of
fusion and fission proteins. The central regulators of
fusion are the mitofusions (Mfn1 and Mfn2). These pro-
teins are necessary to prevent unchecked fission, which
can lead to hyper fragmented mitochondria [2]. The
principal protein responsible for fission is Drp1 (Dynamin-
related protein 1). Several groups have specifically
linked Drp1 and excessive mitochondrial fragmentation
to neurodegeneration [3]. First discovered and charac-
terized in yeast (DNM1P) [4], human Drp1 (DNM1L)
was shown to promote mitochondrial fission in human
cells [5]. Drp1 is a primarily cytoplasmic protein which,* Correspondence: hfox@unmc.edu
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distribution, and reproduction in any mediumwhen activated, can form ring-like multimers and
translocate to the mitochondria. There, in concert
with accessory proteins, Drp1 facilitates mitochondrial
scission [6]. Drp1 activity and cellular localization are
highly regulated by post-translational modifications in-
cluding phosphorylation, ubiquitination, sumoylation,
and N-linked nitrosylation [7]. Here we characterize
the ability of autophagy to regulate protein expression
of Drp1.
Macroautophagy, here referred to as autophagy, is a
mechanism of degradation and recycling of proteins be-
ginning with sequestration of cytoplasmic proteins into
double-membrane vesicles followed by fusion with the
lysosome and subsequent protein degradation. Autophagy
is initiated by multiple cellular cues including starvation
and has extensive roles in numerous cellular processes
and pathophysiologic mechanisms [8]. First characterized
in yeast, autophagy is regulated by a highly conserved fam-
ily of ATG (autophagy-related) genes. In mammalian cells,
the process can be actuated by mTOR inhibition as welltral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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ation of the autophagic membrane involves two ubiquitin-
like conjugation systems where Atg7 (an E1-like enzyme)
works in conjunction with Atg3 or Atg10 (both E2-like) to
conjugate Atg5 to Atg12 and light chain 3 (LC3, homolog
of Atg8) to phosphatidylethanolamine (PE), respectively.
Atg7-deficient cells display impaired autophagosome for-
mation and lysosomal protein turnover [9]. While the
non-PE conjugated form of LC3 (known as LC3-I) is
present in the cytoplasm, the PE-conjugated form (LC3-II)
is then attached to the autophagosomes and represents a
marker for autophagosomes. The autophagosomes then
deliver their contents to the lysosome via fusion. Experi-
mentally, several chemical inhibitors, including bafilomycin
A1 and chloroquine, can inhibit this autophagosomal-lyso-
somal fusion. Autophagy specific for mitochondria, termed
mitophagy, has also been shown to play an increasingly im-
portant role in regulation of mitochondrial dynamics [10].
Various lines of evidence point to altered mitochondrial
dynamics as an underlying pathologic mechanism contrib-
uting to many neurodegenerative conditions including
Alzheimer’s (AD), Parkinson’s (PD), and Huntington’s
(HD) diseases [11,12]. Because of their metabolic require-
ments, neurons are exquisitely dependent on proper mito-
chondrial function including appropriate fusion and
fission. Mutations of the principal proteins responsible for
mitochondrial fusion and fission are seen in several neuro-
logical disorders. MFN2 mutations are seen in patients
with Charcot-Marie Tooth Neuropathy Type 2 [13]. Opa1,
a protein responsible for inner mitochondrial membrane
fusion, is mutated in autosomal dominant Optic Atrophy
Type 1 [14,15]. A neonatal lethal mutation in DNM1L,
which inhibits proper Drp1 mitochondrial assembly,
was characterized in a patient with microcephaly, abnor-
mal brain development, and optic atrophy [16,17]. Several
groups have highlighted the importance of Drp1 function
in neurodegeneration [3]. In a mouse model of AD,
neuronal Drp1 is upregulated and increased Drp1 activity
is thought to occur in the brains of AD patients, which
may contribute to the characteristic pathology [18,19].
In HD, Drp1 associates with mutant Huntington protein
altering normal mitochondrial axonal movement [20].
In a PD neuroblastoma cell line model, downregu-
lation of Drp1 protects from the neurotoxic effects of
6-hydroxydopamine [21]. Work by several groups investi-
gating familial PD, often caused by PARK2 or PINK1 mu-
tations, shows autophagy serves a neuroprotective role
and that autophagy is in part responsible for mitochon-
drial morphology, additionally these groups have found in-
creased fission these PD model systems [22-24]. Together
these data support a role of increased Drp1 and increased
Drp1 activity as a culprit in neurodegeneration. Here we
characterize a general mechanism of Drp1 turnover
through autophagy. We show that autophagic regulationmay be exploited using existing FDA-approved com-
pounds to lower Drp1 levels in neurons.
Results and discussion
Inhibition of autophagosomal-lysosomal degradation
increases Drp1 Levels
To understand how autophagy affects the endogenous
levels of Drp1, we used bafilomycin A1 to decrease au-
tophagic protein degradation. Bafilomycin inhibits the
lysosomal vacuolar H+ ATPase and autophagosomal-
lysosomal fusion and is a commonly used inhibitor of
autophagic degradation. Bafilomycin treatment in HEK-
293T cells increased the expression of Drp1 at both
4 and 24 hours (Figure 1A). To ensure the efficacy of
this bafilomycin treatment to inhibit autophagic turn-
over, levels of LC3 were also analyzed, confirming inhib-
ition of autophagosomal-lysosomal fusion with increased
LC3-II levels. To investigate whether proteasomal inhib-
ition would have a similar effect, as previously reported
[25], we analyzed the effect of the proteasome-specific
inhibitor MG132. Treatment with MG132 did increase
the levels of Drp1 at 4 hours, although not as dramatic-
ally as bafilomycin treatment. These data suggested that
although proteasomal-mediated turnover of Drp1 occurs
in these cells, inhibiting autophagic turnover has a more
dramatic effect on Drp1 protein expression levels. To
confirm that this is not a bafilomycin-specific effect,
treatments with other lysosomal inhibitors, chloroquine
(autophagosomal-lysosomal fusion inhibitor) and a com-
bination of the lysosomal protease inhibitors, pepstatin
and E64D, were used. At both 4 and 24 hours there were
increased levels of Drp1 in chloroquine-treated cells cor-
responding with increased LC3-II levels (Figure 1B).
Similarly, the combination of E64D and pepstatin was
able to increase the level of Drp1 protein in HEK-293T
cells after 24 hours (Figure 1C). To determine if this ef-
fect is cell line dependent, SH-SY5Y were treated with a
similar regimen of bafilomycin and MG132 (Figure 1D).
After 24 hours, a comparable increase in Drp1 level was
seen after bafilomycin treatment, a lower level of in-
crease was also seen in the MG132 treated cells. The
data from the combination of autophagic inhibitors and
multiple cell lines together suggest levels of Drp1 ex-
pression are considerably dependent on autophagy.
Blocking autophagy increases the mitochondrial fraction
of Drp1
In order to determine if blocking autophagy is also in-
creasing the levels of the mitochondrially-associated Drp1,
cytosolic and mitochondrial fractions of HEK-293T cells
treated with bafilomycin were isolated. Bafilomycin in-
creased Drp1 in both the cytosolic and mitochondrial frac-
tion in these cells (Figure 2A). To ensure that the increase
of Drp1 was specifically autophagy-mediated we created
Figure 1 Drp1 expression is increased after inhibiting autophagy. (A) HEK-293T cells were incubated with DMSO, Bafilomycin (100 nM), or
MG132 (25 μM) for 4 hours and 24 hours and whole cell lysate was analyzed by Western blotting using the indicated antibodies. LC3 levels
confirm the bafilomycin is inhibiting autophagic turnover and total ubiquitin levels confirm MG132 effect. (B) HEK-293T cells were incubated with
chloroquine (10 μM) for 4 hours and 24 hours followed by Western blotting (C) Lysosomal protease inhibitors E64D (10 μg/ml) and pepstatin
(10 μg/ml) were incubated with HEK-293T cells for 24 hours. (D) SH-SY5Y cells were incubated with DMSO, bafilomycin (100 nM), or MG132
(25 μM) for 24 hours.
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were transfected with an ATG7 shRNA plasmid and
transfected cells were selected with hygromycin. These
knockdown cells again demonstrated an increased Drp1
level after autophagy is perturbed by ATG7 knockdown
(Figure 2B). Next we selected several different ATG7
knockdown clones and analyzed the levels of Drp1 in the
mitochondrial fraction by immunoblotting (Figure 2C).
Each of the clones demonstrated an increased Drp1 level
in the mitochondrial fraction. Taken together, the results
from both the pharmacological and genetic approaches to
inhibiting autophagy suggest not only does autophagy
regulate overall Drp1 levels but, autophagy is responsible
for the levels of mitochondrially-associated Drp1, the cel-
lular pool ultimately responsible for fission.
Induction of neuronal autophagy lowers endogenous
Drp1 levels
Imbalanced mitochondrial fusion and fission has been well
characterized in neurodegeneration [26]. Increased Drp1
levels in AD [18] and HD patients [27], and cellular data
from PD models all suggest that increased Drp1 isassociated with pathogenesis. With this and evidence for
autophagy-mediated turnover of Drp1 in mind, we studied
the possible effect of inducing autophagy in a primary neu-
rons. The compound 10-NCP has been found to potently
induce autophagy in primary neurons [28]. Using cultured
E18 rat-derived striatal neurons, 10-NCP is able to reduce
Drp1 levels in a dose-dependent manner with a corre-
sponding increase in LC3-II levels (Figure 3A). This effect
is also time dependent and Drp1 is effectively decreased by
24 hours of 10-NCP treatment (Figure 3B). The previous
study of 10-NCP in neurons also identified several
FDA-approved structural analogs, which were able to
analogously induce autophagy [28]. We were interested to
see if these compounds would act similarly to 10-NCP in
these neurons. Both compounds tested (chlorpromazine
and trifluoperazine) were able to decrease Drp1 in a similar
time dependent manner to 10-NCP (Figure 3C-D). To con-
firm the functional relevance of Drp1 downregulation, E18
rat-derived striatal neurons were treated with vehicle or 10-
NCP along with transduction of a mitochondrially-targeted
GFP (Figure 3E). It appears that 10-NCP leads to decreased
fission as mitochondria become more interconnected after
Figure 2 Bafilomycin and ATG7 knockdown increases mitochondrial Drp1. (A) Cytosolic and mitochondrial fractions from bafilomycin
treated HEK-293T cells were isolated by differential centrifugation and analyzed by immunoblotting. *Drp1 antibody reactive band that is only
seen in the mitochondrial fraction. Cox IV is used as a mitochondrial loading control and Actin indicates most of the cytosol is absent from the
mitochondrial fraction. (B) ATG7 stable knockdown clones were created and whole cell lysate was subject to immunoblotting. (C) Mitochondrial
fractions of ATG7 knockdown clones were isolated and lysates were probed with the indicated antibodies. VDAC is used as a mitochondrial
loading control.
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drial morphology was analyzed using a well-characterized
image analysis program (ImageJ plug-in) [22]. After 10-
NCP treatments, mitochondrial size is increased in a large
percentage of the neuronal mitochondria (Figure 3F). To
better quantify this effect, the average and distribution of
mitochondrial size and length (defined by the major mito-
chondrial axis) in control and 10-NCP treated neurons is
shown (Figure 3G-H). These data suggest the induction of
autophagy in neurons is able to decrease Drp1 and this ap-
proach may be useful to decrease the aberrant Drp1 ex-
pression observed in neurodegeneration.
Conclusions
Drp1 is the primary protein responsible for mitochon-
drial fission and as many groups have shown, increased
Drp1 and increased fission are well characterized in sev-
eral neurodegenerative diseases [3,12]. In this study we
have demonstrated a pathway for Drp1 autophagicdegradation. Chemical inhibition of lysosomal degrad-
ation and ATG7 knockdown increased Drp1 levels. Fur-
ther, activation of autophagy in neurons with multiple
compounds, including two that are already FDA ap-
proved, were able to decrease Drp1 levels. We demon-
strate that Drp1 protein turnover is not limited to one
proteolytic system and there is likely interplay between
the autophagic system and the UPS in order to finely
tune Drp1 expression. The ubiquitination of Drp1 by
Parkin [25] and the ability of Parkin to induce both
K48- and K63-linked ubiquitin chains [29], certainly
hints to the importance of the interaction and balance
between these two systems. In our neuronal system
however, Drp1 levels are quite sensitive to induction of
autophagy. We hypothesize that the neuroprotective ef-
fect of autophagy inducers may in part be due to their
ability to reduce Drp1 mediated mitochondrial fission
effectively counteracting the increased fission observed
in neurodegeneration.
Figure 3 Inducing autophagy decreases Drp1 levels in rat-derived striatal neurons. (A) E18 rat-derived striatal neurons were incubated
with 10-NCP at the concentrations indicated for 12 hours. (B) Neurons were incubated with 5 μM 10-NCP for the indicated times. (C and D)
Chlorpromazine and Trifluoperazine (5 μM) was incubated for the times indicated followed by Western blotting. (E) Striatal neurons were
incubated with 10-NCP for 12 hours along with transduction of CellLight Mitochondria GFP to allow labeling and visualization of mitochondria.
(F) Frequency distribution of mitochondrial size in control and 10-NCP treated neurons as quantitated from confocal immunofluorescent images
using the Mitochondrial Morphology plug-in for ImageJ (n > 500 for each condition, X-axis truncated at 200). (G and H) Box and whisker plot
(with whiskers representing 5-95th percentile) of the average mitochondrial size and major axis per neuron (n = 20). *P < 0.05.
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Chemicals and cell line culture
Bafilomycin A1 and MG132 were from Tocris Bioscience.
Chloroquine, Chlorpromazine, E64D, Pepstain, and Tri-
fluoperazine were from Sigma. 10-NCP was from EMD
Millipore. The following drug concentrations were used
unless noted: Bafilomycin (100 nM in DMSO), MG132
(25 μM in DMSO), Chloroquine (10 μM in H2O), Chlor-
promazine (5 μM in H20), Trifluoperazine (5 μM in H20),
and 10-NCP (5 μM in H20). HEK-293T cells were
maintained in DMEM with 10% fetal bovine serum and
SH-SY5Y were maintained in DMEM/F12 with 10% fetal
bovine serum, both were obtained from the American
Type Culture Collection (ATCC).Antibodies
The following antibodies and concentrations were used
for Western blotting. Drp1 (5391, 1:2500, Cell Signaling
Technology), LC3 (M152-3B, 1:5,000, MBL), Ubiquitin
(3936, 1:2500, Cell Signaling Technology), Actin (A2668,
1:20,000, Sigma), GAPDH (437000, 1:20,000, Sigma),
and ATG7 (sc-33211, 1:1000, Santa Cruz).
Mitochondrial isolation and Western blotting
Whole cells were harvested by rinsing with cold PBS,
scraped, and lysed with CelLytic M (Sigma). Mitochondria
were isolated using a mitochondrial isolation kit for cul-
tured cells using the standard protocol (Mitosciences).
Briefly, 1×107cells were homogenized and resuspended in
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were once again homogenized followed by a high-speed
(12,000 x g) centrifugation to collect mitochondria. Super-
natant before the mitochondria isolation step was col-
lected as the cytosolic fraction. Equal amounts of protein
were resolved by SDS-PAGE and transferred to nitrocellu-
lose. Membranes were then blocked and incubated at 4°C
overnight with primary antibodies. Membranes were then
rinsed and incubated for 1–2 hours at RT with appropriate
anti-mouse or anti-rabbit HRP-conjugated secondary anti-
bodies (EMD Millipore) followed by incubation with
SuperSignal Chemiluminescent Substrate (Pierce). Chemi-
luminescent images were acquired on an Image Station
4000MM (Carestream Molecular Imaging).
Generation of ATG7 knockdown cell lines
To generate stable ATG7-deficient cells, HEK-293T cells
were transfected with ATG7 shRNA encoding plasmids
(pSilencer2.1-U6 Hygro vector, Ambion) targeted to the fol-
lowing sequences of human ATG7: ACAAGAGAAAGC
TGGTCATCAA and AAGGAGTCACAGCTCTTCCTT
(Kindly provided Dr. Hui Pan, UNMC). Stable clones were
then selected with cloning discs followed by growth in 250
μg/ml hygromycin B containing media for 21 days. After
selection, knockdown was verified by immunoblotting
(Figure 2A).
Isolation and culture of primary neurons
All animal experiments were performed following NIH
guidelines under approval from the UNMC IACUC. E-
18 rat striatal neurons were isolated using a previously
established protocol and plated as described onto poly-D
lysine coated coverslips [30]. Treatments with 10-NCP,
chlorpromazine and trifluoperazine were performed after
14 days in culture.
Mitochondrial imaging of primary neurons
Fourteen days after plating, cells were incubated with a
half-exchange of media alone or media containing 10-
NCP and CellLight Mitochondria GFP (Invitrogen) for
12 hours. Neurons were then fixed for 20 minutes with
3.7% paraformaldehyde and mounted with ProlongGold
containing DAPI (Invitrogen). Slides were imaged on a
Zeiss 710 Confocal Laser Scanning Microscope at 63×
and Zeiss Zen imaging software. For quantification of
mitochondrial morphology a workflow was used based
on the methods described by the Strack group [31].
Briefly, the mitochondrial labeled channel was isolated
and converted to a monochrome image. This image was
then 2-D deconvolved using the Iterative Deconvolution
ImageJ plug-in (Bob Dougherty, http://www.optinav.com/
imagej.html Iterative), and converted to a binary image in
ImageJ. Finally, the Mito-Morphology Macro was used to
quantitate shape [22].Statistical analysis
Where appropriate, experiments were performed three in-
dependent times; values represent mean plus standard
error of triplicate experiments. Two-sided P-values < 0.05
were considered significant.
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